ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC ESMO Colloquium

Immune-Check Points Inhibitors (ICI) in non-oncogenic addicted mNSCLC

Lecture Time
12:50 PM - 01:15 PM
Session Name
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC
Speakers
  • Marina C. Garassino
Location
Hall 407, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM
Authors
  • Marina C. Garassino